Masimo Corp Rating Lowered to Underperform at Zacks (MASI)

By admin | 6 years ago

Masimo Corp (NASDAQ: MASI) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a report issued on Wednesday. They currently have a $18.00 target price on the stock.

Shares of Masimo Corp opened at 19.48 on Wednesday. Masimo Corp has a one year low of $17.62 and a one year high of $35.15. The company has a market cap of $1.117 billion and a P/E ratio of 19.12.

Masimo Corp last issued its quarterly earnings data on Wednesday, May 2nd. The company reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by $0.01. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, analysts predict that Masimo Corp will post $0.28 earnings per share next quarter.

Separately, analysts at Raymond James (NYSE: RJF) initiated coverage on shares of Masimo Corp in a research note to investors on Wednesday, April 25th. They set a “market perform” rating on the stock.

Masimo Corporation is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products that improve patient care.

About the author